-
Helpful Apps for People Living with Cancer
As mobile apps become more ingrained in our lives, it’s natural to look for ones that can help manage a cancer diagnosis. As for which app to choose, it really comes down to what you’re looking for...
IN THE SPOTLIGHT
-
Clinical Trial Phases
The four phases of lung cancer clinical trials each serve a different and important purpose. From testing the safety of a new treatment to its effectiveness and long-term outcomes... -
Drs. Susumu Kobayashi and Alexandre Reuben Announced as Recipients of EGFR Resisters/LUNGevity Research Award
LUNGevity Foundation is thrilled to announce the recipients of the EGFR Resisters/LUNGevity Research Award for EGFR-Positive Lung Cancer. EGFR Resisters, a vibrant patient-led... -
LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards
LUNGevity Foundation is proud to announce the recipients of four awards to bolster the lung cancer research workforce— the Career Development Award, the VA Research Scholar Award... -
Treatment & Research Takeaways: ESMO 2023 Meeting
The European Society for Medical Oncology (ESMO) recently held its annual conference from October 20 – 24, 2023 in Madrid, Spain. ESMO represents one of the largest gatherings of... -
EGFR Virtual Meetup
EGFR patients/survivors - Join us the 1st Wednesday of every month to connect with others who share common experiences and build your community. -
Transportation to Treatment
At some point, transportation to appointments becomes a challenge for everyone. Whether it be the cost, time commitment, or finding reliable transportation, we share some tips for... -
What Is a Clinical Trial
Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. They give people the ability to participate in lung... -
Watch Recorded Expert Sessions From ILCSC
The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference for people with lung cancer, caregivers, and advocates. The 2023 conference...
EGFR+ Lung Cancer: Going Beyond Osimertinib
EGFR+ Lung Cancer: Going Beyond Osimertinib
Learn about what's next once osimertinib stops working in EGFR+ lung cancer. EGFR Resisters co-founders Jill Feldman and Ivy Elkins, and 2021 EGFR Resisters/LUNGevity Foundation awardees Christine Lovly, MD, PhD, and Helena Yu, MD, share updates for the community. This video was recorded on Facebook Live on May 11, 2023.
A Survivor’s Experience with Biomarker Testing and TKI Treatments
A Survivor’s Experience with Biomarker Testing and TKI Treatments
Back in 2013, when Dan Cadigan was first diagnosed with stage III lung cancer, his treatment options were limited to surgery followed by chemotherapy. However, at his one-year follow-up scan, they found nodules in both lungs and he was diagnosed with stage IV recurrent cancer.Normally, it would have meant a return to chemo for treatment.But instead, thanks to a biomarker test that found an epidermal growth factor receptor (EGFR) mutation in the cancer cells, Dan was eligible for a new targeted…
Being a Caregiver for a Parent
Being a Caregiver for a Parent
Being a caregiver for a parent means helping in different ways and playing different roles. For Aimee Yairi, it started when her dad told her that he was having a lingering cough in early 2021. The fear was that he had caught COVID. His primary care physician continued ordering x-rays for her father and prescribing different medications for pneumonia, asthma, and GERD—but resisted sending him to a specialist. Aimee advocated for her father to get a CT scan. And that was when the 7 cm tumor was…
Beloved Reporter Goes Public with His Lung Cancer Diagnosis
Beloved Reporter Goes Public with His Lung Cancer Diagnosis
A familiar voice to many in the greater Washington, DC area, Neal Augenstein, a beloved reporter at WTOP radio, joined fellow lung cancer survivor Melinda Ojermark to discuss his experience with lung cancer. Neal has a family history of the disease, so when a persistent cough would not go away, he asked his doctor for screening. A low-dose CT scan revealed that Neal had lung cancer, the same disease that had taken his father's life. Since receiving a Stage IV diagnosis in late-2022, Neal has…
Joanne G. Shares her Story
Joanne G. Shares her Story
My lung cancer journey began back in February 2021, by happenstance. I didn’t have any of the classic symptoms, other than I didn’t feel well and I was unusually tired. I reluctantly caved to a trip to the local emergency room for what appeared to be an abdominal hernia or aneurysm.The physician ordered an angio CT scan that revealed a lung mass in the upper lobe of my right lung, which lucky for me was not accompanied by a suspected aortic aneurysm. After many consultations and further testing…
Let Your Voice Be Heard!
Let Your Voice Be Heard!
We are collecting stories from patients, caregivers, friends, and family members! Tell us how lung cancer has affected your life. Email your story to us at support@lungevity.org. Thanks!
RET, MET, and EGFR: An unusual tale of three oncogenes in lung cancer
RET, MET, and EGFR: An unusual tale of three oncogenes in lung cancer
LUNGevity's Upal Basu Roy, PhD, MPH, Executive Director, Research, discusses innovative research into RET+ NSCLC with patient advocates and the scientist conducting the studies. Panelists include Omaima Salous (diagnosed with RET+ NSCLC and co-founder of The Hamoui Foundation), Dr. Hilary Hammell (diagnosed with RET+ NSCLC and co-chair of RETpositive), and Dr. Tejas Patil (Assistant Professor, University of Colorado). The discussion focuses on Dr. Patil’s RET+ NSCLC research project and why…